Literature DB >> 22315648

Congenital hyperinsulinism with hyperammonaemia.

Alex Pschibul1, Jörg Müller, Hubert Fahnenstich.   

Abstract

Congenital hyperinsulinism is considered to be the most frequent cause of persistent recurrent hypoglycaemia in infants. The clinical presentation and response to pharmacological treatment may vary significantly depending on the underlying pathology. We report a case of a female infant with mild but early onset of recurrent hypoglycaemia. Metabolic workup revealed hyperinsulinism combined with mild hyperammonaemia as well as elevation of α-ketoglutarate in urine. Genetic testing demonstrated a de novo mutation in exon 7 of the glutamate dehydrogenase gene on chromosome 10. Episodes of hypoglycaemia responded to treatment with diazoxide. The differential diagnosis, pathophysiology and treatment of congenital hyperinsulinism is discussed.

Entities:  

Year:  2010        PMID: 22315648      PMCID: PMC3030263          DOI: 10.1136/bcr.08.2009.2174

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  Molecular basis and characterization of the hyperinsulinism/hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators.

Authors:  C A Stanley; J Fang; K Kutyna; B Y Hsu; J E Ming; B Glaser; M Poncz
Journal:  Diabetes       Date:  2000-04       Impact factor: 9.461

2.  Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene.

Authors:  C A Stanley; Y K Lieu; B Y Hsu; A B Burlina; C R Greenberg; N J Hopwood; K Perlman; B H Rich; E Zammarchi; M Poncz
Journal:  N Engl J Med       Date:  1998-05-07       Impact factor: 91.245

3.  Hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase.

Authors:  C MacMullen; J Fang; B Y Hsu; A Kelly; P de Lonlay-Debeney; J M Saudubray; A Ganguly; T J Smith; C A Stanley
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

4.  Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients.

Authors:  P De Lonlay; C Benelli; F Fouque; A Ganguly; B Aral; C Dionisi-Vici; G Touati; C Heinrichs; D Rabier; P Kamoun; J J Robert; C Stanley; J M Saudubray
Journal:  Pediatr Res       Date:  2001-09       Impact factor: 3.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.